This purpose of this study is to determine the ability of an 18F-fluoro-L-dihydroxyphenylalanine (18F-DOPA) PET (Positron Emission Tomography) scan to detect a focal lesion of hyperinsulinism and determine the location in patients with congenital hyperinsulinism, Beckwith Wiedemann Syndrome and suspected insulinoma. Safety data will be collected.
Patients with hyperinsulinemic hypoglycemia are at risk for neurological damage due to hypoglycemia. Early surgical intervention can be preventative. F-DOPA PET may be able to detect of a focal lesion prior to surgical intervention and be used during surgical planning to guide the surgical procedure.
Study Type
EXPANDED_ACCESS
18F-DOPA is a PET (Positron Emission Tomography) scan radiotracer.
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
AVAILABLEThis platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.